The European Laboratory Research and Innovation Group (ELRIG) UK has today announced the keynote speakers for its upcoming Research and Innovation Conference at the University of Manchester on 20-21 March. Steve Bates OBE FMedSci CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-Founder and Head of R&D and Drug Development, FasT BioPharma will lead this year’s event which will focus on accelerating drug discovery.
This free-to-attend event will bring together scientists, researchers and entrepreneurs to discuss how emerging biology and innovative technologies can help guide tomorrow’s medicines and enable next-generation therapeutics. It will have four main sessions covering animal-free technologies, oncology drug discovery, tackling antimicrobial resistance as well as advances in mass spectrometry techniques and proteomics. There will also be a trade show and exhibition, a poster competition and a host of networking opportunities.
Steve Bates leads the BIA, the UK trade association for innovative life sciences companies. A strong advocate of partnership working, Steve Champions is committed to collaborating with sector research charities and academia, and developing the next generation of talent and skills needed to grow the sector. He serves on the UK Government’s Life Sciences Council and Vaccine Taskforce as well as the UK Biosecurity Leadership Council. Steve has helped enable effective industry incentives, such as biomedical catalysts, and forged links for sectors across the US, Europe and China. Prior to joining the BIA, Steve worked at Genzyme and was a UK government advisor to Tony Blair. He was appointed an OBE for innovation in 2017 and became a Fellow of the Academy of Medical Sciences in 2020.
Dr. Anderson Ryan is the scientific co-founder of FasT BioPharma, an oncology-focused start-up, where he leads the R&D program. He previously served in several roles, including VP Head of Oncology at Mission Therapeutics, Head of Translational Science at Medicines Discovery Catapult, and leading translational science programs across a broad range of preclinical and clinical oncology indications at AstraZeneca. Anderson was previously a lecturer in cancer studies at the University of Manchester and an associate professor and senior MRC group leader in the Department of Oncology at the University of Oxford, investigating new therapeutic approaches in lung cancer. He has trained over 20 postgraduate students, published over 200 scientific papers and 12 patents and acted as an oncology/drug-development reviewer for key funders including CRUK, UKRI and Innovate UK.
ELRIG Research and Innovation to Launch TechBio Breakthrough Zone in 2024 The new exhibition space provides opportunities for young companies to present their technology and connect with potential customers and collaborators. ELRIG also has the opportunity to nominate early-career professionals for an Impact Award that will recognize an individual for their scientific contribution and impact on early-stage drug discovery.
Sarah Brockbank, Conference Director, ELRIG UK and Strategic Leader – Complex Medicines, Medicines Discovery Catapult, said: “We have an outstanding line-up of speakers covering the key focus areas of drug discovery and development. These world-leading experts will share their insights and experiences about the challenges and opportunities in the field, and we are honored to have Steve Bates and Dr. Anderson Ryan on board as keynote speakers.”
Roger Clarke, Conference Director, ELRIG UK and Head of High Throughput Screening, Charles River Laboratories, said: “We look forward to welcoming scientists from academia and industry to the University of Manchester, celebrating its bicentenary this year — the perfect setting to share bold ideas to accelerate future drug discovery and reflect on transformative achievements that have paved the way for new generations of therapeutics. “
I am thrilled to be speaking at ELRIG Research and Innovation this year. The event presents an excellent opportunity to connect, collaborate and discuss the latest innovations for the vibrant life science industry. This is vital to the community’s success as we strive to discover and develop new medicines to cure more patients around the world.”
Steve Bates OBE FMedSci, CEO, Bioindustry Association
Dr. Anderson Ryan, Co-Founder and Head of Research and Development and Drug Development, Fast Biopharma: “The organizers have put together a great line-up packed with interesting talks, poster presentations, exhibitors and networking opportunities. I am proud to attend such an exciting event, offering researchers and entrepreneurs many opportunities to discover emerging biology and cutting-edge technologies, including from young companies. There is.”